Jasmeet Singh to Maximum Tolerated Dose
This is a "connection" page, showing publications Jasmeet Singh has written about Maximum Tolerated Dose.
Connection Strength
0.061
-
Johnson ML, Patel MR, Falchook GS, Koyama T, Gutierrez M, Awad MM, Piha-Paul SA, Friedman CF, Satoh T, Okamoto N, Singh J, Yoshizuka N, Windish HP, Qian M, Tran BP, Doi T. Ifinatamab deruxtecan, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial. Lancet Oncol. 2026 Apr; 27(4):491-501.
Score: 0.061